- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.30 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x X1A: N-(5-{[6-(5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-yl)-2,6-diazaspiro[3.4]octan-2-yl]methyl}-1,3-thiazol-2-yl)acetamide(Non-covalent)
- 1 x CA: CALCIUM ION(Non-covalent)
- 9 x SO4: SULFATE ION(Non-functional Binders)
SO4.3: 4 residues within 4Å:- Chain A: V.311, S.312, N.313, G.314
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:N.313
SO4.4: 5 residues within 4Å:- Chain A: N.285, K.290, D.328, P.329, S.330
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:N.285, A:S.330
- Salt bridges: A:K.290
SO4.5: 3 residues within 4Å:- Chain A: R.317, A.318, Y.319
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:A.318
- Water bridges: A:Y.319
- Salt bridges: A:R.317
SO4.6: 3 residues within 4Å:- Chain A: R.359, N.360, D.394
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:N.360, A:N.360
SO4.9: 5 residues within 4Å:- Chain B: G.308, V.311, S.312, N.313, G.314
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:N.313, B:G.314
SO4.10: 2 residues within 4Å:- Chain B: R.317, A.318
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:A.318
- Salt bridges: B:R.317
SO4.11: 3 residues within 4Å:- Chain B: R.234, F.235, D.236
4 PLIP interactions:4 interactions with chain B- Hydrogen bonds: B:F.235, B:D.236, B:D.236
- Salt bridges: B:K.276
SO4.12: 2 residues within 4Å:- Chain B: R.359, N.360
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:D.358, B:N.360, B:N.360
SO4.13: 4 residues within 4Å:- Chain B: R.523, S.570, F.571, A.572
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:F.571
- 1 x CL: CHLORIDE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Martinez-Viturro, C.M. et al., Diazaspirononane Nonsaccharide Inhibitors of O-GlcNAcase (OGA) for the Treatment of Neurodegenerative Disorders. J.Med.Chem. (2020)
- Release Date
- 2020-12-02
- Peptides
- O-GlcNAcase NagJ: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
EB
F
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.30 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x X1A: N-(5-{[6-(5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-yl)-2,6-diazaspiro[3.4]octan-2-yl]methyl}-1,3-thiazol-2-yl)acetamide(Non-covalent)
- 1 x CA: CALCIUM ION(Non-covalent)
- 9 x SO4: SULFATE ION(Non-functional Binders)
- 1 x CL: CHLORIDE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Martinez-Viturro, C.M. et al., Diazaspirononane Nonsaccharide Inhibitors of O-GlcNAcase (OGA) for the Treatment of Neurodegenerative Disorders. J.Med.Chem. (2020)
- Release Date
- 2020-12-02
- Peptides
- O-GlcNAcase NagJ: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
EB
F